A Phase 1, Randomized, Double-Blind, Placebo-Controlled Study To Assess The Safety, Tolerability, And Pharmacokinetics Of PF-06678552 After Administration Of Multiple Escalating Oral Doses In Healthy Adult Subjects

Trial Profile

A Phase 1, Randomized, Double-Blind, Placebo-Controlled Study To Assess The Safety, Tolerability, And Pharmacokinetics Of PF-06678552 After Administration Of Multiple Escalating Oral Doses In Healthy Adult Subjects

Completed
Phase of Trial: Phase I

Latest Information Update: 07 Aug 2014

At a glance

  • Drugs PF 6678552 (Primary)
  • Indications Hypercholesterolaemia
  • Focus Adverse reactions
  • Sponsors Pfizer
  • Most Recent Events

    • 30 Jul 2014 Status changed from recruiting to completed as reported by ClinicalTrials.gov record.
    • 30 May 2014 According to the ClinicalTrials.gov record, planned end date changed from 1 Aug 2014 to 1 Jun 2014.
    • 01 Apr 2014 According to the ClinicalTrials.gov record, status changed from not yet recruiting to recruiting.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top